49,886 Shares in LifeVantage Corp (NASDAQ:LFVN) Purchased by Alambic Investment Management L.P.

Share on StockTwits

Alambic Investment Management L.P. purchased a new position in shares of LifeVantage Corp (NASDAQ:LFVN) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 49,886 shares of the company’s stock, valued at approximately $658,000. Alambic Investment Management L.P. owned approximately 0.35% of LifeVantage as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of LFVN. Manatuck Hill Partners LLC increased its holdings in LifeVantage by 510.2% in the 3rd quarter. Manatuck Hill Partners LLC now owns 454,570 shares of the company’s stock worth $4,996,000 after purchasing an additional 380,070 shares in the last quarter. Renaissance Technologies LLC boosted its position in shares of LifeVantage by 36.1% during the 3rd quarter. Renaissance Technologies LLC now owns 1,011,805 shares of the company’s stock valued at $11,120,000 after purchasing an additional 268,354 shares in the last quarter. Acadian Asset Management LLC boosted its position in shares of LifeVantage by 190.9% during the 3rd quarter. Acadian Asset Management LLC now owns 291,624 shares of the company’s stock valued at $3,204,000 after purchasing an additional 191,382 shares in the last quarter. BlackRock Inc. boosted its position in shares of LifeVantage by 210.9% during the 3rd quarter. BlackRock Inc. now owns 238,160 shares of the company’s stock valued at $2,618,000 after purchasing an additional 161,555 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of LifeVantage by 76.5% during the 3rd quarter. Dimensional Fund Advisors LP now owns 258,262 shares of the company’s stock valued at $2,838,000 after purchasing an additional 111,974 shares in the last quarter. 32.30% of the stock is owned by institutional investors.

LFVN stock opened at $14.18 on Thursday. LifeVantage Corp has a fifty-two week low of $3.20 and a fifty-two week high of $17.08. The company has a market cap of $206.69 million, a P/E ratio of 27.80 and a beta of 0.76. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.06 and a current ratio of 1.52.

LifeVantage (NASDAQ:LFVN) last posted its quarterly earnings results on Monday, February 4th. The company reported $0.13 EPS for the quarter. The firm had revenue of $58.17 million during the quarter. LifeVantage had a return on equity of 35.08% and a net margin of 2.92%. On average, equities research analysts forecast that LifeVantage Corp will post 0.49 earnings per share for the current year.

WARNING: “49,886 Shares in LifeVantage Corp (NASDAQ:LFVN) Purchased by Alambic Investment Management L.P.” was originally published by Fairfield Current and is the property of of Fairfield Current. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://www.fairfieldcurrent.com/news/2019/03/14/alambic-investment-management-l-p-buys-shares-of-49886-lifevantage-corp-lfvn.html.

LifeVantage Profile

LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.

Featured Article: What are economic reports?

Institutional Ownership by Quarter for LifeVantage (NASDAQ:LFVN)

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply